Gudrun Werner
Gudrun Werner, Wien AT
Patent application number | Description | Published |
---|---|---|
20080269312 | Inhibitors of Ccr9 Activity - N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents. | 10-30-2008 |
20080275114 | Inhibitors of Ccr9 Activity - Compounds of formula (I), in which R | 11-06-2008 |
20080300295 | Inhibitors of Ccr9 Activity - Compounds of formula I, wherein one of R | 12-04-2008 |
20080312313 | Inhibitors of Ccr9 Activity - A compound of formula (I), wherein the residues have various meanings, useful as pharmaceuticals. | 12-18-2008 |
20090215044 | Receptor in Dendritic Cells - GPBAR1 for use as a target for selective inhibition of Th1 mediated immune responses. | 08-27-2009 |
20100261758 | HETEROCYCLIC AMIDES FOR USE AS PHARMACEUTICALS - Compounds of Formula (I) wherein R | 10-14-2010 |
Gudrun Werner, Vienna AT
Patent application number | Description | Published |
---|---|---|
20090208997 | GPR18 as a Biomaker for TH1 Mediated Immune Response - The present invention provides the use of GPR18 in diseases or disorders mediated by Th1 cell activation. | 08-20-2009 |
20090317827 | Receptor In Dendritic Cells - The present invention provides the use of GPR91 as a target in dendritic cells. | 12-24-2009 |